Oxidative stress in blood of HIV infected patients

Clinica Chimica Acta

Volumn 255, Issue 2, 1996, Pages 107-117

  Repetto, Marisa ^a   Reides, Claudia ^a   Gomez Carretero, Maria L ^b   Costa, Marta ^b   Griemberg, Gloria ^b   Llesuy, Susana ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Chemiluminescence; Erythrocytes; Human immunodeficiency virus; Oxidative stress

Indexed keywords

ANTIBIOTIC AGENT; CATALASE; DIDANOSINE; GLUTATHIONE; SUPEROXIDE DISMUTASE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; OPPORTUNISTIC INFECTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030606336     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06394-2     Document Type: Article

References (18)

1. [1] Clerici M, Stocks NI, Zajac RA et al. Detection to three distinct paterns of T-helper cell disfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J Clin Invest 1989;84:1892-1899.
2. [2] Buhl R, Holroyd KJ, Mastrangeli A et al. Glutathione deficiency in symptom free HIV seropositive individuals. Lancet 1989;2:1294-1298.
3. [3] Javier JJ, Fodyce-Baum MK, Beach RS, Gavancho M, Cabrejos C, Mantero-Atienza E. Antioxidants, micronutrients and immune function in HIV-1 infection. FASEB Procite 1990;4A:940.
4. [4] Halliwell B, Cross CE. Reactive oxygen species, antioxidants and acquired immunodeficiency syndrome. Sense or speculation?. Arch Intern Med 1991;151:29-31.
5. [5] Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-k:B transcription factor and HIV-1. EMBO J 1991;10:2247-2258.
6. [6] Piette J, Legrand-Poels S. HIV-1 reactivation after an oxidative stress mediated by different reactive oxygen species. Chem Biol Interac 1994;91:79-89.
7. [7] Cross C, Halliwell B. Oxygen radicals in human disease. Ann Intern Med 1987;107:526-545.
8. [8] Council of state and territorial epidemiologists. AIDS Program center for Infections diseases, Centers for disease control. Revision of the CDC suveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36:35-155.
9. [9] Costa L, Llesuy S, Boveris A. Active oxygen species in the lives of rats submitted to chronic hypobaric hypoxia. Am J Physiol 1993;264 (Cell Physiol, 33):c1395-c1400.
10. [10] Akerboom TPM, Sies H. Assay of glutathione disulfide and glutathione mixed disulfides in biological samples. Methods Enzymol: New York: Academic Press 1981;77:373-382.
11. [11] Lissi E, Pascual C, Del Castillo M. Luminol luminescence induced by 2,2′-azobis(2-amidinopropane) thermolysis. Free Rad Res Commun 1992;17:299-311.
12. [12] Lowry OH, Roseborough A, Farr AL, Randall RS. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
13. [13] Drabkin DL, Austin J. Spectrophotometric studies: preparation from washed blood cells, Nitric oxide haemoglobin and sulfahaemoglobin. J Biol Chem 1935;112:51-57.
14. [14] Alloisio N, Michelson D, Bannier E, Revol A, Beuzard Y, Delaunay J. Alteration of red cell membrane proteins and hemoglobin under natural and experimental oxidant stress. Biochim Biophys Acta 1982;691:300-308.
15. [15] Favier A, Sappey C, Leclerc P, Faure P, Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 1994;91:165-180.
16. [16] De Quay B, Malinverni R, Lauterburg B. Glutathione depletion in HIV infected patients: role of cysteine deficiency and effect of oral N-acetyl cysteine. AIDS 1992;6:815-819.
17. [17] Beach R, Mantero-Antienza E, Shor-Posner G. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992;6:701-708.
18. [18] Leff J, Oppegard M, Curiel T, Brown K, Schooley R, Repine J. Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection. Free Rad Biol Med 1992;113:143-149.